Adherence to Treatment in Hemophilia

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-05-31

Study Completion Date

2016-02-29

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Psychosocial factors and adherence to treatment in patients with hemophilia. A multicenter study. Multicenter cross sectional study of patients with hemophilia and their families

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Association of Prophylactic Treatment With Treatment Burden and Psychosocial Variables in Patients With Hemophilia

NCT07099313

Hemophilia

RECRUITING

Development of a Specific Measure for Assessing Adherence in Adult Patients With Hemophilia.

NCT02197611

Haemophilia

UNKNOWN

Study Evaluating Approach to Treatment of Haemophilia A and B in Spain

NCT00581438

Hemophilia A Hemophilia B

COMPLETED

Multidisciplinary Evaluation of Patients With Hemophilia

NCT02198430

Haemophilia

COMPLETED

Transcultural Multidisciplinary Evaluation of Patients With Hemophili

NCT02199639

Patients With Haemophilia

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Research project whose main objective is to assess adherence and major psychosocial issues affecting patients with hemophilia and their families treated at the Hematology and hemotherapy Services Clinical Hospital Universitario Virgen de la Arrixaca of Murcia and the University Hospital Carlos Haya, Malaga.

The data obtained in this project will identify those psychosocial aspects affecting patients and their families about the disease, its evolution and treatment of it. They will use different psychosocial questionnaires based on scientific evidence and the reliability of these, as well as its specific design for hemophilia patients. The main characteristics of the study are:

* Descriptive study of adherence to treatment of pediatric patients, adolescents and adults with hemophilia.
* Descriptive study of family functioning, perceived stress, anxiety and quality of life in parents of children with hemophilia under 14 years and adolescents with hemophilia, depending on the administered medical treatment, clinical and musculoskeletal patient situation.
* Descriptive study of illness behavior or perception of illness, perceived stress, anxiety, quality of life and coping strategies of young adults with hemophilia, depending on the medical treatment administered, and skeletal muscle clinical situation of the patient.
* Validation of psychosocial assessment tools in patients with hemophilia and their families.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Haemophilia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

CROSS_SECTIONAL

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Patients with haemophilia

Hemophilia patients (children, youth and adults) and parents of children with hemophilia under 18

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients with hemophilia A or B
* Patients followed at the Hematology Department of the hospitals included in the study
* Patients without cognitive disorders

Exclusion Criteria

* Patients with other congenital coaguopatías
* Patients with more than 2 years without going to review your hospital
* Patients from other provinces of Spain

Minimum Eligible Age

6 Years

Maximum Eligible Age

75 Years

Eligible Sex

MALE

Accepts Healthy Volunteers

No